Vertex Pharmaceuticals
VRTX
#173
Rank
C$163.60 B
Marketcap
C$638.12
Share price
-1.25%
Change (1 day)
-2.27%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: C$163.60 Billion

As of December 2025 Vertex Pharmaceuticals has a market cap of C$163.60 Billion. This makes Vertex Pharmaceuticals the world's 173th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$163.60 B8.31%
2024C$151.05 B8.62%
2023C$139.06 B38.25%
2022C$100.58 B41.22%
2021C$71.22 B-9.11%
2020C$78.36 B5.81%
2019C$74.06 B28.58%
2018C$57.60 B20.88%
2017C$47.64 B94.05%
2016C$24.55 B-42.88%
2015C$42.99 B28.99%
2014C$33.33 B80.26%
2013C$18.49 B104.24%
2012C$9.05 B28.5%
2011C$7.04 B-1.14%
2010C$7.12 B-20.95%
2009C$9.01 B72.44%
2008C$5.22 B69.78%
2007C$3.07 B-43.96%
2006C$5.49 B57.71%
2005C$3.48 B239.8%
2004C$1.02 B-2.12%
2003C$1.04 B-45.2%
2002C$1.91 B-34.99%
2001C$2.94 B-53.96%
2000C$6.38 B392.51%
1999C$1.29 B11.78%
1998C$1.15 B-2.44%
1997C$1.18 B2.22%
1996C$1.16 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Vertex Pharmaceuticals was reported to be:

C$161.90 Billion
by Nasdaq info icon info icon
C$163.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$212.28 B 29.75%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$563.97 B 244.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$351.59 B 114.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$147.55 B-9.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$680.64 B 316.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C$0.56 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA